MedTrace Logo

Cochlear Implantation in Cases of Single-Sided Deafness

NCT02203305 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 43

Last updated 2022-07-25

Study results available
· View outcomes & findings →

Summary

The primary goal of this project is to determine whether subjects with Single-Sided Deafness (SSD) experience an improvement in speech perception, localization, and quality of life with a cochlear implant as compared to an unaided listening condition.

Conditions

  • Unilateral Moderate to Profound Hearing Loss
  • Asymmetric Hearing Loss
  • Single-Sided Deafness (SSD)

Interventions

DEVICE

Cochlear Implant

cochlear implantation used a treatment for single-sided deafness and/or asymmetric hearing loss

OTHER

Control Group

Subjects in the control group will have had listening experience with a bone-conduction device, which is an approved treatment for SSD.

Sponsors & Collaborators

  • Med-El Corporation

    collaborator INDUSTRY

  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • Margaret Dillon, AuD · University of North Carolina, Chapel Hill

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2021-09-16
Completion
2021-09-16

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02203305 on ClinicalTrials.gov